Steen Jakobsen

Biodistribution and radiation dosimetry of [N-methyl-11C]mirtazapine, an antidepressant affecting adrenoceptors

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Central adrenoceptors cannot currently be studied by PET neuroimaging due to a lack of appropriate radioligands. The fast-acting antidepressant drug mirtazapine, radiolabelled for PET, may be of value for assessing central adrenoceptors, provided that the radiation dosimetry of the radioligand is acceptable. To obtain that information, serial whole-body images were made for up to 70 min following intravenous injection of 326 and 185 MBq [N-methyl-11C]mirtazapine (specific activities E.O.S. of 119 and 39G Bq/micromol, respectively) in a healthy volunteer. Ten source organs plus remaining body were considered in estimating absorbed radiation doses calculated using MIRD 3.1. The highest absorbed organ doses were found to the lungs (3.4 x 10(-2) mGy/MBq), adrenals (1.2 x 10(-2) mGy/MBq), spleen (1.2 x 10(-2) mGy/MBq), and gallbladder wall (1.1 x 10(-2) mGy/MBq). The effective dose was estimated to be 6.8 x 10(-3) mSv/MBq, which is similar to that produced by several radioligands used routinely for neuroimaging.
Original languageEnglish
JournalApplied Radiation and Isotopes
Pages (from-to)175-9
Number of pages5
Publication statusPublished - 2012

    Research areas

  • Adult, Brain, Carbon Radioisotopes, Female, Humans, Metabolic Clearance Rate, Mianserin, Organ Specificity, Radiation Dosage, Radiometry, Radiopharmaceuticals, Receptors, Adrenergic, Tissue Distribution, Tomography, Emission-Computed, Whole-Body Counting

See relations at Aarhus University Citationformats

ID: 44024885